Though unprofitable last year and burdened with debt, Innovative Medical Management seems able to manage its debt due to a solid net cash position. However, slow growth and a cash burn of CN¥21m with a loss of CN¥75m means they might need additional capital soon if break-even isn't reached.
创新医疗股票讨论区
暂无评论